LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| Hs 578T | Geldanamycin | 0.8279 |
| Hs 578T | GW843682X | 0.8294 |
| BT-20 | Radicicol | 0.8310 |
| Hs 578T | PHA-793887 | 0.8310 |
| MCF 10A | PD0325901 | 0.8397 |
| Hs 578T | Dactolisib | 0.8502 |
| SK-BR-3 | Celastrol | 0.8600 |
| MCF7 | JNK-9L | 0.8608 |
| MDA-MB-231 | Barasertib | 0.8612 |
| SK-BR-3 | AZD 5438 | 0.8629 |
| BT-20 | AT-7519 | 0.8635 |
| MCF 10A | Barasertib | 0.8646 |
| Hs 578T | AZD8055 | 0.8649 |
| MCF 10A | Tozasertib | 0.8650 |
| MCF7 | Buparlisib | 0.8654 |
| MCF 10A | AZD8330 | 0.8654 |
| MCF7 | Barasertib | 0.8699 |
| MCF7 | PI103 | 0.8713 |
| Hs 578T | Torin1 | 0.8745 |
| BT-20 | Dasatinib | 0.8755 |
| MCF7 | WYE-125132 | 0.8763 |
| MCF7 | XMD16-144 | 0.8821 |
| SK-BR-3 | Pictilisib | 0.8859 |
| MDA-MB-231 | Trametinib | 0.8871 |
| SK-BR-3 | Buparlisib | 0.8877 |